Related Experiment Video
Updated: Jul 15, 2026

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
Published on: March 27, 2018
How end-stage renal disease (ESRD)-medicare developed
1Georgetown University School of Medicine, Washington, DC, USA.
Uremia, a toxic condition from kidney or systemic diseases, can be fatal. Dialysis and transplantation emerged as treatments, leading to the development of end-stage renal disease (ESRD) Medicare.
Area of Science:
- Nephrology
- Toxicology
- Medical History
Background:
- Uremia is a severe, toxic condition resulting from numerous kidney and systemic diseases, historically challenging medical understanding and treatment.
- Despite its fatal nature, uremia has been a persistent medical challenge since ancient times, driving efforts to prolong patient lifespans.
Observation:
- The development of dialysis and kidney transplantation provided effective, albeit complex and costly, treatments for uremia.
- Catastrophic events like crush syndrome and nephritis during wartime highlighted the urgent need for advanced uremia treatments.
Findings:
- The evolution of substitution therapy for uremia involved integrating clinical, basic science, and industrial technology.
- The legislative establishment of end-stage renal disease (ESRD) coverage, known as ESRD-Medicare, provided a framework for widespread treatment access.
Implications:
- The development of ESRD-Medicare represents a significant societal and governmental response to a critical medical need.
- Understanding the historical progression of uremia treatment, including the political and social organization, offers insights into medical policy development.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care

